Bayer, Asklepios hemophilia B deal

Asklepios (Chapel Hill, N.C.) and Bayer Healthcare, a unit of Bayer (FSE:BAYG; BAY), partnered to evaluate Asklepios' synthetic biological nano particle (BNP) gene therapy containing the Factor IX (FI...